dihydrouracil has been researched along with pyrimidin-2-one beta-ribofuranoside in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beumer, JH; Covey, JM; Egorin, MJ; Eiseman, JL; Joseph, E | 1 |
| Beumer, JH; Covey, JM; D'argenio, DZ; Egorin, MJ; Eiseman, JL; Joseph, E; Parker, RS | 1 |
2 other study(ies) available for dihydrouracil and pyrimidin-2-one beta-ribofuranoside
| Article | Year |
|---|---|
Quantitative determination of zebularine (NSC 309132), a DNA methyltransferase inhibitor, and three metabolites in murine plasma by high-performance liquid chromatography coupled with on-line radioactivity detection.
Topics: Animals; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Cytidine; DNA Modification Methylases; Drug Stability; Male; Mice; Mice, Inbred Strains; Online Systems; Reproducibility of Results; Sensitivity and Specificity; Specific Pathogen-Free Organisms; Spectrophotometry, Ultraviolet; Uracil; Uridine | 2006 |
A mass balance and disposition study of the DNA methyltransferase inhibitor zebularine (NSC 309132) and three of its metabolites in mice.
Topics: Animals; Chromatography, High Pressure Liquid; Cytidine; DNA Modification Methylases; Male; Mice; Uracil; Uridine | 2006 |